A prospective study of benign breast disorders at B.P. Koirala Institute of Health Sciences, Dharan, Nepal
Abstract
Objectives: To know the spectrum of benign breast disorders presenting to Surgery outpatient department or emergency at BPKIHS.
Aim: To study the medical or surgical treatment modalities in benign breast disorders,To find out the outcome of treatment of benign breast disorders.
Methods: Inclusion Criteria: One hundred and sixty-one patients of either sex were randomly assigned found to have breast related symptoms like pain, lump, nipple discharge or fever, were included in the study. Male patients presenting with gynaecomastia also included. With clinical or histopathological evidence of malignant breast disease excluded. Included following investigations1.Total counts and differential, 2. Chest X-ray, ECG, 3. Breast abscess diagnosed on clinical ground, 4. FNAC, 5. USG of breast, 6. Mammography of the breast, 7. Imprint cytology.
Management: either conservatively or surgically. follow up at one week, one month, three month and explained importance of follow up.
Result: The mean age were 15-66 years, 70% were 20-40 years, 96.9% were females and 3.1% male, 83.9% married & 16.1% were unmarried. The duration of illness ranged from 2days to 4380 days with mean of 258.99 days. Acute illness (n=70) had mean of 5.11 days and chronic illness (n=91) had a mean of 454.27 days, complained of lump in breast (n=149) followed by pain (n=140). Discharge from nipples in 5 patients, fever in 44 patients. One with retraction of nipple. Both pain and lump in 127 cases whereas 13 had only mastalgia and 22 had only lump in breast.
Conclusion: This is understandable and to allay their fear, an understanding of benign breast disorder is essential Hence, in a country like Nepal, education regarding breast self-examination and proper follow up is highly recommended so that early treatment is sought.
Downloads
References
Agrawal V. Fibrocystic Disease. In: Agarwal N, Suneja A. Female Breast Gynaecologist Viewpoint. 2000, Jaypee, FOGSI Publication, Delhi, 178-190.
Hutter RVP. Goodbye to “Fibrocystic disease” N Engl J Med. 1985;312:179-181. doi: 10.1056/NEJM198501173120311.
Sharma A, Bandari R, Gilbert D, Sharma A.K. Benign and malignant breast disease presenting to Bhaktapur Cancer Hospital. Kathmandu Univ Med J. (KUMJ). 2005;3(4):384-387.
Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd, et al. American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin. 2003;53(3):141-169. doi: https://doi.org/10.3322/canjclin.53.3.141.
Caleffi M, Filho DD, Borghetti K, Graudenz M, Littrup PJ, Freeman-Gibb LA, et al. Cryoablation of benign breast tumors: evolution of technique and technology. Breast 2004;13(5):397-407. doi:https://doi.org/10.1016/j.breast.2004.04.008.
Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990; 12(1):228–240. doi: https://doi.org/10.1093/oxfordjournals.epirev.a036056.
Chinson WB, Thomas DB, Hamlin WB et al. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst. 1980;65(1):13-20.
Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat. 1985;6(1):5-36.
Drukker BH. Fibrocystic Change of Breast. In: Pitkim RM and ScottJR (eds). JB Lippencott Company, Philadelphia, Pennsylvania, 1994,37(4): 903-915.
Ernster VL. The Epidemiology of Benign Breast Disease. Epidemiol Rev. 1981;3(1):184-202. doi: https://doi.org/10.1093/oxfordjournals.epirev.a036233
Itzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122(12):1053-1055.
Khan S, Kapoor A.K, Khan I.U. Shrestha G.B. Singh P, Prospective study of pattern of breast disease at Nepalganj Medical College, Nepal. Kathmandu Univ Med J (KUMJ).2003;1(2):95-100.
Arnelli R, Squartini F. Fibrocystic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol. 1991;18(4):271-279.
Shukla HS, Kumar S. Benign Breast Disorders in Nonwestern Populations Part-II – Benign Breast Disorders in India. World J Surg. 1989;13(6):746-749.
Iyer SP, Gore MA. Epidemiology of benign breast diseases in females of childbearing age group. Department of Surgery, LTMGH and Medical College, Sion, Mumbai. Bombay Hospital J. 2000;42(1):141-146.
Wazer DE, Gage I, Horner MJ, Krosmick SH, Schmid C. Age related differences with non-palpable breast carcinomas. Cancer. 1996;78(7):1432-1437.
La Vecchia C, Parazzini F, Franceschi S, Decarli A. Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori. 1985;71(2):167-178.
Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL Risk factors for benign proliferative breast disease. Int J Epidemiol. 2000;29(4):637-644. doi: https://doi.org/10.1093/ije/29.4.637.
Santen RJ, Mansel R. Benign Breast Disorders. New Eng J Med. 2005;353(3):275-285. doi: 10.1056/NEJMra035692.
Markopoulos C, Kouskos E, Kontzoglou K, Gogas G, Kyriakou V, Gogas J.. Breast cancer in ectopic breast tissue. Eur J Gynaecol Oncol. 2001;22(2):157-159.
OAI - Open Archives Initiative
Therapoid
